Suchergebnisse - "Tabernero, J"

PubPharm (9)

1

Biomarker analysis beyond angiogenesis : RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Yoshino, T. | Portnoy, D. | Obermannová, R. | +19

2

Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Tabernero, J. | Hozak, R. | Yoshino, T. | +15

CommentIn: Ann Oncol. 2018 Mar 1;29(3):527-529. - PMID 29360914

3

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

enthalten in: British journal of cancer | 2015

von Macarulla, T. | Cervantes, A. | Tabernero, J. | +10

4

Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer : the randomised phase I/II POSEIDON trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Élez, E. | Kocáková, I. | Höhler, T. | +14

5

Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer

enthalten in: British journal of cancer | 2013

von Joulain, F. | Proskorovsky, I. | Allegra, C. | +4

6

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Cohn, A. | Tabernero, J. | Maurel, J. | +15

7

A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2012

von Starling, N. | Vázquez-Mazón, F. | Cunningham, D. | +12

8

Cetuximab administered once every second week to patients with metastatic colorectal cancer : a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2010

von Tabernero, J. | Ciardiello, F. | Rivera, F. | +10

9

Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study

enthalten in: Acta oncologica (Stockholm, Sweden) | 2008

von Abad, A. | Massuti, B. | Antón, A. | +12

1
[1]